SMHS Doctorate in Biomedical Sciences

The Doctorate in Biomedical Science program trains researchers in the preclinical medical area as experts who:

• Are part of interdisciplinary teams that link basic and clinical researchers.
• Can propose, based on care needs (patient bedside), working hypotheses that can be applied.
• Are ideal for validating in vitro or in vivo experimental models that closely reproduce the diseases that are the object of study.
• Are interested in investigating physiopathological mechanisms, to discover therapeutic targets, diagnostic markers, test new drugs, design therapeutic devices.
• To put their maximum effort into committing to make their findings impact on applied healthcare.
• Can communicate to the scientific community, with rigor, precision, and depth, the findings obtained that will lead to publications, scientific articles, patents, or technological developments.

The Doctorate in Biomedical Sciences guides its future graduates toward the achievement, in the medium term, of the following results:

• To be entrepreneurial leaders that stand out for their ability to propose, manage and develop cutting-edge biomedical innovation and research projects.
• To be researchers with a human outlook, that contribute to generating new knowledge in the field of biomedical science that impacts on social well-being.  
• To be professionals with a global vision and international competitiveness who collaborate in interdisciplinary research teams, actively participate in scientific networks and professional associations, and contribute to training qualified experts for biomedical research and innovation. 
   

• Diseases secondary to inflammation and oxidative damage: cardiovascular, chronic liver disease, cirrhosis, pulmonary fibrosis, neurodegenerative diseases, cancer, and autoimmune diseases.
• Growth, endocrine, and nutritional diseases. Metabolic syndrome, delayed intrauterine growth, diabetes and its complications (renal, cardiovascular, ophthalmologic, etc.), gestational diabetes, obesity, polycystic ovary. 
• Technique innovation, validation of biomedical devices, biosimilars, and bioinformatics and biophysical applications, and nanomedicine. 
   

• Present the Admission Test for Graduate Studies (PAEP) or its equivalent in the Graduate Record Examination (GRE) with a minimum score of 600.
• Proof of master’s degree with a minimum average of 90 to apply for a scholarship of excellence (100% tuition scholarship) (COPY).
• Proven English proficiency with a minimum TOEFL or ITP score of 600.
• Admission application.
• Letter of intent.
• Three letters of recommendation.
• Birth certificate.
• Approval from the academic faculty.

In this graduate program, the aim is to develop professionals capable of leading basic and clinical research, collaborating with national and international research groups in priority areas, such as:

Applied Molecular Medicine:

• Biomarkers in Perinatal Medicine: a study of the sTREM1 fraction in neonatal sepsis.
• Participation of pro-inflammatory cytokines in heart failure.
• Management of intracellular calcium and energy production in the myocardium.  
• Ion channels and cardiac arrhythmias.
• Cardiovascular imaging.
• Identification and purification of new molecules of natural origin with cardioprotective activities.
• Biomarkers (proteomics model) for survival, response, and resistance in lymphomas, myelomas, gastrointestinal tumors, and breast cancer.  
• Use of natural drugs in pre-clinical models of lymphoma.
• Circadian rhythm and chemoresistance in breast cancer.
• Gene expression and its relationship with survival and resistance to treatment.

Clinical innovation

• Delayed intrauterine growth and polycystic ovary syndrome as IGF-1 deficiency conditions: effect of replacement therapy.
• Expression of genes involved in lipid and glucose metabolism in conditions of IGF-1 deficiency: experimental approximation to metabolic syndrome 
• Lymphoma clinical trials
• Immuno-modulation for the treatment of inflammatory conjunctivitis and non-infectious uveitis.
• Preventive and therapeutic methods for presbyopia.
• Igf-1 and neuroprotection.

Cellular therapy 

• Study of differentiated stem cells in animals.
• Treatment with autologous stem cells for patients with chronic degenerative diseases.
• Regeneration of ganglion fibers of the optic nerve by means of progenitor cells.
• Osteoblasts from adipose stem cells: applications.
• Osteogenesis Imperfecta, Traumatology, and Dentistry.
• Differentiation from stem cells to muscle cells on three-dimensional scaffolds.

To obtain a specialty diploma, a master's degree, a medical specialty degree, or a doctor's degree at Tecnológico de Monterrey, the following are required:

• To have completely finished the undergraduate professional cycle prior to the approval of the first course of the curriculum of the specialty, master's, medical specialty, or doctorate.
• To have fulfilled, in accordance with the current regulations, the previous academic requirements of the corresponding curriculum through taking the pertinent placement exams, proficiency exams, or remedial courses.
• To have obtained a professional degree – which is preceded by a high school degree or its equivalent – that is equivalent to that taught at the Tecnológico de Monterrey.
• To have covered all of the subjects in the respective study plan, either by passing all subjects at the Tecnológico de Monterrey or by obtaining revalidation or equivalence agreements – in accordance with the corresponding norms – of part of the subjects studied at other institutions and passing the remaining subjects at the Tecnológico de Monterrey. For the purposes of this article, subjects taken at foreign universities with which we have agreements will be considered as taken at the Tecnológico de Monterrey, as long as they do not exceed a certain percentage of the study plan established for each particular program.
• For those curricula that require it, to have prepared a research project or thesis that has been presented and approved by an academic jury.
• To have completed at least the equivalent of the second half of the corresponding study plan at the Tecnológico de Monterrey, for those students that have revalidation or equivalency agreements for studies at this level.  There may be flexibility in this rule for graduate programs that have an agreement established with other universities.
• In the case of Doctoral programs, to have published in indexed journals (or have evidence of acceptance for publication) at least one article on a topic related to your research project.